John M. Hatcher

Also affiliated with International Waldenstrom's Macroglobulinemia Foundation, Dana-Farber Cancer Institute

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Development of CDK2 and CDK5 Dual Degrader TMX‐2172”.

Development of CDK2 and CDK5 Dual Degrader TMX‐2172

Angewandte Chemie International Edition(2020)10.1002/anie.202004087

N/A

0DataRank · unranked

78 citations

Jie Jiang, Zhixiang He, Nicholas Kwiatkowski, Katherine A. Donovan, Caitlin E. Mills +7 more

Discovery of a Selective, Covalent IRAK1 Inhibitor with Antiproliferative Activity in MYD88 Mutated B-Cell Lymphoma

ACS Medicinal Chemistry Letters(2020)10.1021/acsmedchemlett.0c00378

N/A

0DataRank · unranked

28 citations

Guang Yang, Li Wang, Scott B. Ficarro, Sara J. Buhrlage, Hao Wu +4 more

Development of CDK2 and CDK5 Dual Degrader TMX‐2172

Angewandte Chemie(2020)10.1002/ange.202004087

N/A

0DataRank · unranked

5 citations

Jie Jiang, Zhixiang He, Nicholas Kwiatkowski, Katherine A. Donovan, Caitlin E. Mills +7 more

Development and Utility of a PAK1-Selective Degrader

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.2c00756

N/A

0DataRank · unranked

31 citations

Sofiia Karchugina, Brian J. Groendyke, Sean T. Toenjes, John M. Hatcher, Katherine A. Donovan +7 more

A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non–Small Cell Lung Cancer

Cancer Research(2022)10.1158/0008-5472.can-21-2693

N/A

0DataRank · unranked

36 citations

Jaebong Jang, Tyler S. Beyett, Yoonji Eum, Heidi M. Haikala, Alyssa Verano +13 more

Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors

Cancer Research(2022)10.1158/0008-5472.can-21-4309

N/A

0DataRank · unranked

17 citations

Minjee Kim, Gabriela Alexe, Kathleen Engel, Alexandra B. Forman, Amanda L. Robichaud +10 more

Development and utility of a PAK1-selective degrader

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.12.491715

N/A

0DataRank · unranked

2 citations

Sofiia Karchugina, Brian J. Groendyke, Sean T. Toenjes, John M. Hatcher, Katherine A. Donovan +7 more

Catalytic Degraders Effectively Address Kinase Site Mutations in EML4-ALK Oncogenic Fusions

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.2c01864

N/A

0DataRank · unranked

42 citations

Baishan Jiang, Hellen Kim, Matthew J. Berberich, Jianwei Che, Katherine A. Donovan +13 more

ERK1/2 pro‐survival signalling is suppressed by pirtobrutinib in ibrutinib‐resistant MYD88‐mutated lymphoma cells

British Journal of Haematology(2024)10.1111/bjh.19756

N/A

0DataRank · unranked

3 citations

Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Zachary R. Hunter, Maria Luisa Guerrera +15 more

Allosteric inhibition of JAK2 with lysine-reactive compounds that bind the pseudokinase domain

European Journal of Medicinal Chemistry(2025)10.1016/j.ejmech.2025.118274

N/A

0DataRank · unranked

4 citations

Maurício T. Tavares, John M. Hatcher, Hyelim Kang, Tomás A. C. Kresina, Sayan Chakraborty +9 more

Development and characterization of the novel MYD88 mutated, 6q deleted BCWM.2 cell line for Waldenström macroglobulinaemia

British Journal of Haematology(2025)10.1111/bjh.20072

N/A

0DataRank · unranked

1 citations

Xia Liu, Choudhury Fabliha B. Yusuf, Amanda Kofides, Kara M. Soroko, Johany Peñailillo +17 more

Repurposing pacritinib to target MYD88 ‐mutated Waldenström macroglobulinaemia

British Journal of Haematology(2025)10.1111/bjh.70254

N/A

0DataRank · unranked

0 citations

Amanda Kofides, Xia Liu, John M. Hatcher, Hao Sun, Nicholas Tsakmaklis +11 more